Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV Patients
Clinical trial NCT05970289 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05970289
- Sponsor
- Brii Biosciences Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-22
- Primary completion
- 2025-07-16
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.